Lawrence Hunsicker is a Nephrology physician affiliated with University of Iowa. OpenAlex indexes 198 publications with 45,967 citations (h-index 62). By OpenAlex citation count, this profile ranks in the top 5% of Nephrology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Hawkins Dr
Iowa City, IA 522421009
Telephone
319-356-4763Registry record last updated 23 Jul 2009.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20246 payments$12,945openpaymentsdata.cms.gov ↗
- Lexicon Pharmaceuticals, Inc.Program year20243 payments$11,397openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
6 NIH research awards on record, funded 1985–2007 per NIH RePORTER. The latest:
- FOLIC ACID FOR VASCULAR OUTCOME REDUCTION IN TRANSPLANTATION (FAVORIT)
University of Iowa
FY2007$22,793M01RR000059 - LONG-TERM DETERIORATION OF KIDNEY ALLOGRAFT FUNCTION (DEKAF)
University of Iowa
FY2007$2,171M01RR000059 - FOLIC ACID FOR VASCULAR OUTCOME REDUCTION IN TRANSPLANTATION (FAVORIT)
University of Iowa
FY2006$65,514M01RR000059
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes
American Journal of Transplantation
2020 - Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
The Lancet Diabetes & Endocrinology
2019 - Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies
The Lancet Diabetes & Endocrinology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Brian Olshansky, MD
University of Iowa
Robert Weiss, MD
University of Iowa
Elliott Sohn, MD
University of Iowa
Abdullah Abbasi, MD
University of Iowa
Andrew Levey, MD
Tufts Medical Center
Glenn M. Chertow
FIND
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”